Dados do Trabalho

Título

QUALITY AND VALUE-BASED HEALTHCARE (VBHC) FOR PATIENTS WITH NON-METASTATIC COLON CANCER AT A BRAZILIAN REFERRAL HOSPITAL

Introdução

Focused on best practices, our institution has value-based healthcare (VBHC) and International Consortium for Health Outcomes Measurement (ICHOM). We reported clinical data of patients with colon cancer, mapping pathological characteristics and treatments in order to improve the quality of the medical care provided.

Objetivo

Evaluate methods of diagnosis, treatment and follow-up of patients diagnosed with colorectal cancer in a private hospital. Determine whether standard care in the organization is in line with defined gold care and further assess patient-reported outcomes.

Método

Observational, prospective, longitudinal study with patients diagnosed with colon cancer, stages I-III, from February 2018 to April 2021, at our institution. A prospective cohort is being followed from 180 days to 5 years after diagnosis evaluating clinical outcomes. Statistical analysis was performed using SAS (Statistical Analysis System), version 9.4, and the statistical significance was defined as p<0.05

Resultado

Fifty-nine patients with non-metastatic colon cancer were diagnosed and treated; 57,6% were female; mean age 66.8 years (SD, 12.4 [37.0-91.0]); 38.9% were stage II, 35.5% stage III and 25.4% stage I. A mean of 27.1 [9.0-61.0] lymph nodes were analyzed. On stage II patients, 43% had high risk features and 13% had indication for adjuvant chemotherapy. Microsatellite instability was evaluated in 30.4%. The high rate of non-indication of adjuvant chemotherapy in patients in stage II was due to 52% of these patients been ≥70 years. On stage III, adjuvant chemotherapy was performed in 85%; mFOLFOX-6 in 56%.

Conclusão

At our institution, the treatment recommended in patients with colon cancer clinical stages I-III was adequate. Longer follow up is necessary for overall survival, progression-free survival and long-term quality of life.

Palavras-chave

Cancer, Colorectal, Patient-reported outcomes, Value-based-healthcare,

Área

Oncologia - Tumores TGI Inferior (cólon/reto/ânus)